NCT00005630View on ClinicalTrials.gov

Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Primary Completion Date

May 31, 2002

Study Completion Date

May 31, 2002

Conditions
Lung Cancer
Interventions
BIOLOGICAL

ras peptide cancer vaccine

BIOLOGICAL

sargramostim

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00005630 - Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter